Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Jones

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pharmaceutical Statistics|October 27, 2018
Lessons from meta-analyses of randomized clinical trials for analysis of distributed networks of observational databasesAndrew Bate, Christy Chuang-Stein, Andrew Roddam, et al.
Pharmaceutical Statistics|July 20, 2022
Response to the letter to the editor regarding our article 'statistical methodology for highly variable compounds: A novel design approach for the ofatumumab phase 2 bioequivalence study' https://doi.org/10.1002/pst.2233Byron Jones, Bingbing Li, Morten Bagger, et al.
Pharmaceutical Statistics|May 23, 2022
Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab Phase 2 bioequivalence studyByron Jones, Bingbing Li, Morten Bagger, et al.
International Journal of Technology Assessment in Health Care|May 2, 2024
Development of a disease-specific health utility score for chronic obstructive pulmonary disease from a discrete choice experiment patient preference studyByron Jones, Mandy Ryan, Nigel S Cook, et al.
The AAPS Journal|November 29, 2018
The Assessment of Quality Attributes for Biosimilars: a Statistical Perspective on Current Practice and a ProposalJohanna Mielke, Franz Innerbichler, Martin Schiestl, et al.
Journal of Managed Care Pharmacy : JMCP|November 15, 2011
Statistical issues with the analysis of nonrandomized studies in comparative effectiveness researchDemissie Alemayehu, Jose Ma J Alvir, Byron Jones, et al.
Engineering Reports : Open Access|January 31, 2023
Evaluating vacant middle seats and masks as Coronavirus exposure reduction strategies in aircraft cabins using particle tracer experiments and computational fluid dynamics simulationsJames S Bennett, Seif Mahmoud, Watts Dietrich, et al.
AAPS Pharmscitech|August 19, 2021
Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence TestingElise Burmeister Getz, Kevin J Carroll, Johanna Mielke, et al.
Clinical Pharmacology and Therapeutics|February 9, 2023
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial DesignsCornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, et al.
Journal of Aircraft|February 3, 2015
Aircraft Recirculation Filter for Air-Quality and Incident AssessmentSteven J Eckels, Byron Jones, Garrett Mann, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pharmaceutical Statistics|October 27, 2018
Lessons from meta-analyses of randomized clinical trials for analysis of distributed networks of observational databasesAndrew Bate, Christy Chuang-Stein, Andrew Roddam, et al.
Pharmaceutical Statistics|July 20, 2022
Response to the letter to the editor regarding our article 'statistical methodology for highly variable compounds: A novel design approach for the ofatumumab phase 2 bioequivalence study' https://doi.org/10.1002/pst.2233Byron Jones, Bingbing Li, Morten Bagger, et al.
Pharmaceutical Statistics|May 23, 2022
Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab Phase 2 bioequivalence studyByron Jones, Bingbing Li, Morten Bagger, et al.
International Journal of Technology Assessment in Health Care|May 2, 2024
Development of a disease-specific health utility score for chronic obstructive pulmonary disease from a discrete choice experiment patient preference studyByron Jones, Mandy Ryan, Nigel S Cook, et al.
The AAPS Journal|November 29, 2018
The Assessment of Quality Attributes for Biosimilars: a Statistical Perspective on Current Practice and a ProposalJohanna Mielke, Franz Innerbichler, Martin Schiestl, et al.
Journal of Managed Care Pharmacy : JMCP|November 15, 2011
Statistical issues with the analysis of nonrandomized studies in comparative effectiveness researchDemissie Alemayehu, Jose Ma J Alvir, Byron Jones, et al.
Engineering Reports : Open Access|January 31, 2023
Evaluating vacant middle seats and masks as Coronavirus exposure reduction strategies in aircraft cabins using particle tracer experiments and computational fluid dynamics simulationsJames S Bennett, Seif Mahmoud, Watts Dietrich, et al.
AAPS Pharmscitech|August 19, 2021
Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence TestingElise Burmeister Getz, Kevin J Carroll, Johanna Mielke, et al.
Clinical Pharmacology and Therapeutics|February 9, 2023
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial DesignsCornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, et al.
Journal of Aircraft|February 3, 2015
Aircraft Recirculation Filter for Air-Quality and Incident AssessmentSteven J Eckels, Byron Jones, Garrett Mann, et al.
Pageof 4